Company Filing History:
Years Active: 2024
Title: Innovations in Male Contraception by Véronique Agathon-Meriau
Introduction
Véronique Agathon-Meriau is an innovative inventor based in Luxembourg, LU. He has made significant contributions to the field of male contraception through his research and development of non-hormonal compositions. His work aims to provide effective contraceptive methods while minimizing side effects commonly associated with traditional formulations.
Latest Patents
Agathon-Meriau holds a patent for "Non-hormonal compositions and methods for male contraception." This invention relates to methods for inducing conditions such as aspermia, azoospermia, or severe oligozoospermia in male subjects. The compositions may include an alpha-1-adrenoreceptor antagonist, such as (R)-silodosin, which is intended for daily administration. The formulations are designed to maintain contraceptive efficacy even with delayed or missed doses, thus offering a reliable alternative to existing methods.
Career Highlights
Véronique Agathon-Meriau is associated with Pharmajor International, where he continues to advance his research in male contraception. His innovative approach has the potential to reshape the landscape of contraceptive options available to men.
Collaborations
Agathon-Meriau collaborates with notable colleagues, including Guillaume El Glaoui and Mehdi El Glaoui. Their combined expertise contributes to the development of groundbreaking solutions in the field of male reproductive health.
Conclusion
Véronique Agathon-Meriau's work in developing non-hormonal contraceptive methods represents a significant advancement in male reproductive health. His innovative approach and dedication to research are paving the way for new possibilities in contraception.